Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lamivudine With or Without Adefovir Dipivoxil for Postoperative Hepatocellular Carcinoma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436042/all/Aripiprazole_for_autism_spectrum_disorders__ASD__New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 09 June 2023.
Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436042/all/Aripiprazole_for_autism_spectrum_disorders__ASD__New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed June 9, 2023.
Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436042/all/Aripiprazole_for_autism_spectrum_disorders__ASD__New_search_for_studies_and_content_updated__no_change_to_conclusions_
Lamivudine With or Without Adefovir Dipivoxil for Postoperative Hepatocellular Carcinoma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 June 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436042/all/Aripiprazole_for_autism_spectrum_disorders__ASD__New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review
ID - 436042
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436042/all/Aripiprazole_for_autism_spectrum_disorders__ASD__New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -